You are here: Industry Insights > Inhibitors

News List

Shanghai Public Health Clinical Center Initiated Functional Cure Study of Anti-PD-L1 Antibody ASC22 (Envafolimab) in Combination With Chidamide in HIV-Infected Patients prnasia
February 15, 2022
Ascletis Pharma Inc. (HKEX: 1672) today announces that Shanghai Public Health Clinical Center initiated functional cure study of anti-PD-L1 antibody ASC22 (Envafolimab) in combination with Chidamide...
FLIP sync: Collaboration for inhibitors and cancer treatments pharmatimes
January 26, 2022
Ipsen and Domainex collaboration will provide an exclusive licence to develop innovative inhibitors and pioneering cancer treatments.
Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers prnasia
January 24, 2022
Applied Pharmaceutical Science, Inc. ("APS" or "the Company"), has recently announced the Investigational New Drug (IND) application for its self-developed breakthrough new drug APS03118...
Octapharma puts a spotlight on the challenges of managing inhibitors in haemophilia A at the 15th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) prnasia
January 20, 2022
The virtual symposium held on Wednesday, February 2, 2022, at 18:00 CET, will tell the story of the Rodriguez family and their two sons with haemophilia A as they navigate the challenges of inhibitor management.
Antihistamines can influence immunotherapy response by enhancing T cell activation FirstWordPharma
November 29, 2021
New research from The University of Texas MD Anderson Cancer Center found that treatment with antihistamines, a commonly used allergy medication, was associated with improved responses to immune checkpoint inhibitors.
Moleculin, UTMB Evaluate Inhibitors for Antiviral Properties contractpharma
March 18, 2020
Moleculin will supply the lead drug candidate, WP1122, and related inhibitors, as well as technical support.
SGLT2 Inhibitors Linked to Lower Risk for Heart Failure drugs
September 23, 2019
Use of sodium glucose cotransporter 2 (SGLT2) inhibitors for type 2 diabetes is associated with a reduced risk for heart failure ...
“Upstar” against Breast Cancer—CDK 4/6 Inhibitors: Which has the Biggest Potential among the Three? PharmaSources/Dopine
August 20, 2019
Targeted therapies have played an increasingly important role in tumor treatment in recent years.
Higher Cost of New Cholesterol Drugs Putting Patients at Risk: Study drugs
July 24, 2019
Heart attacks, strokes and other heart problems are more likely in high-risk patients denied access to cutting-edge cholesterol-busting drugs called?PCSK9 inhibitors...
Newer Drug Extends Lives of Young Breast Cancer Patients drugs
June 03, 2019
Adding a newer drug to standard hormone therapy lengthens the lives of younger women with advanced breast cancer, a new trial has found.